SpyGlass Pharma (SGP) Treasury Shares (2024 - 2025)
SpyGlass Pharma (SGP) posted quarterly Treasury Shares of $20.3 million for Q4 2025, up 111.7% year-over-year from $9.6 million in Q4 2024, and up 111.7% quarter-over-quarter from $9.6 million in Q4 2024.
Powered by 
Analysis
SpyGlass Pharma (SGP) Treasury Shares (2024 - 2025) Analysis & Trends
SpyGlass Pharma (SGP) has reported Treasury Shares for 2 consecutive years, with $20.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares rose 111.7% year-over-year to $20.3 million; the TTM figure through Dec 2025 stood at $20.3 million (up 111.7% YoY), while the FY2025 annual figure was $20.3 million, up 111.7% from the prior year.
- Treasury Shares advanced to $20.3 million in Q4 2025 per SGP's latest filing, from $9.6 million in the prior quarter.
- Across five years, Treasury Shares topped out at $20.3 million in Q4 2025 and bottomed at $9.6 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | SpyGlass Pharma | 973.76 Mn | 973.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 20.34 Mn |
| Dec 31, 2025 | 20.34 Mn |
| Jun 30, 2025 | 20.34 Mn |
| Jun 30, 2025 | 20.34 Mn |
| Dec 31, 2024 | 9.61 Mn |
| Dec 31, 2024 | 9.61 Mn |